First National Bank of Mount Dora’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-33,076
Closed -$878K 135
2024
Q4
$878K Sell
33,076
-3,226
-9% -$87.5K 0.21% 76
2024
Q3
$1.05M Sell
36,302
-48,408
-57% -$1.41M 0.24% 75
2024
Q2
$2.37M Sell
84,710
-35,275
-29% -$971K 0.57% 57
2024
Q1
$3.33M Buy
119,985
+16,703
+16% +$463K 0.81% 47
2023
Q4
$2.97M Buy
103,282
+72
+0.1% +$2.18K 0.79% 52
2023
Q3
$3.42M Sell
103,210
-1,358
-1% -$48K 1.01% 41
2023
Q2
$3.84M Sell
104,568
-1,878
-2% -$73.1K 1.09% 38
2023
Q1
$4.34M Sell
106,446
-13,615
-11% -$588K 1.31% 33
2022
Q4
$6.15M Buy
120,061
+806
+0.7% +$38.6K 2.03% 15
2022
Q3
$5.22M Sell
119,255
-13,275
-10% -$645K 1.85% 14
2022
Q2
$6.95M Buy
132,530
+773
+0.6% +$39.4K 2.39% 9
2022
Q1
$6.82M Buy
131,757
+31,519
+31% +$1.64M 2.06% 14
2021
Q4
$5.92M Buy
100,238
+946
+1% +$46.9K 1.75% 19
2021
Q3
$4.27M Sell
99,292
-1,016
-1% -$45K 1.4% 31
2021
Q2
$3.93M Buy
100,308
+1,101
+1% +$42.8K 1.29% 34
2021
Q1
$3.6M Buy
99,207
+119
+0.1% +$4.22K 1.25% 36
2020
Q4
$3.65M Sell
99,088
-4,410
-4% -$162K 1.32% 36
2020
Q3
$3.6M Buy
103,498
+615
+0.6% +$21.6K 1.49% 28
2020
Q2
$3.19M Sell
102,883
-28,777
-22% -$978K 1.45% 31
2020
Q1
$4.08M Buy
131,660
+6,336
+5% +$216K 2.15% 19
2019
Q4
$4.66M Buy
125,324
+749
+0.6% +$26.7K 1.96% 19
2019
Q3
$4.25M Buy
124,575
+163
+0.1% +$5.93K 1.94% 20
2019
Q2
$5.11M Sell
124,412
-6,556
-5% -$260K 2.36% 11
2019
Q1
$5.28M Sell
130,968
-2,779
-2% -$111K 2.32% 11
2018
Q4
$5.54M Sell
133,747
-844
-0.6% -$35K 2.76% 8
2018
Q3
$5.63M Buy
134,591
+5,961
+5% +$229K 2.42% 10
2018
Q2
$4.43M Buy
128,630
+1,943
+2% +$66.4K 1.98% 21
2018
Q1
$4.26M Sell
126,687
-23,916
-16% -$822K 1.96% 19
2017
Q4
$5.18M Buy
150,603
+6,349
+4% +$216K 2.28% 17
2017
Q3
$4.89M Buy
144,254
+12,435
+9% +$400K 2.4% 16
2017
Q2
$4.2M Buy
131,819
+32,306
+32% +$1.02M 2.18% 20
2017
Q1
$3.23M Buy
99,513
+47,372
+91% +$1.49M 1.74% 28
2016
Q4
$1.61M Buy
52,141
+6,727
+15% +$205K 0.95% 44
2016
Q3
$1.46M Sell
45,414
-2,719
-6% -$90.9K 0.82% 50
2016
Q2
$1.61M Sell
48,133
-184
-0.4% -$5.87K 0.92% 48
2016
Q1
$1.36M Sell
48,317
-5,495
-10% -$157K 0.8% 50
2015
Q4
$1.65M Sell
53,812
-1,212
-2% -$38.1K 0.97% 45
2015
Q3
$1.64M Sell
55,024
-3,294
-6% -$106K 1% 46
2015
Q2
$1.85M Sell
58,318
-10
-0% -$326 1.04% 40
2015
Q1
$1.93M Sell
58,328
-1,950
-3% -$62K 1.04% 40
2014
Q4
$1.78M Sell
60,278
-1,070
-2% -$30.7K 1% 44
2014
Q3
$1.72M Buy
61,348
+685
+1% +$19.2K 1.01% 40
2014
Q2
$1.71M Buy
60,663
+121
+0.2% +$3.45K 0.99% 41
2014
Q1
$1.84M Sell
60,542
-26,271
-30% -$783K 1.12% 38
2013
Q4
$2.52M Buy
86,813
+949
+1% +$27.6K 1.64% 17
2013
Q3
$2.34M Sell
85,864
-1,107
-1% -$30.1K 1.71% 17
2013
Q2
$2.31M Buy
+86,971
New +$2.4M 1.72% 16

Other funds holding PFE

First National Bank of Mount Dora's PFE Position: Q1 2025 in Review

First National Bank of Mount Dora sold out of Pfizer (PFE) in Q1 2025, closing a stake of 33,076 shares — an estimated $878K sold.

First National Bank of Mount Dora first reported a position in PFE in Q2 2013 and held it in 47 quarters. The position peaked at $6.95M in Q2 2022. 2,931 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

  • First National Bank of Mount Dora reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
  • First National Bank of Mount Dora sold 33,076 Pfizer shares in Q1 2025, an estimated $878K.
  • First National Bank of Mount Dora first reported a position in Pfizer in Q2 2013 and held it in 47 quarters.
  • First National Bank of Mount Dora's Pfizer position peaked at $6.95M in Q2 2022.
  • 2,931 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on First National Bank of Mount Dora's 13F filing for Q1 2025, filed 15 Apr 2025.